Mexiletine

Routes
Oral (PO)
Half-Life (t½)
PO: 17h
Formula
C11H17NO
Molecular Weight
179.26 g/mol
PubChem CID
4178
Aliases
Mexitil

Pharmacological Mechanism

Class IB antiarrhythmic — voltage-gated Na+ channel blocker preferentially binding the inactivated state. Used for ventricular arrhythmias + neuropathic pain (off-label) + myotonic syndromes. CYP2D6 substrate.

Half-Life & Elimination Curve (PO: 17h)

100%50%25%12.5%0%0h0×t½17h1×t½34h2×t½51h3×t½68h4×t½3.5d5×t½0×t½ (0h): 100% remaining (~0.384 mg/L)1×t½ (17h): 50% remaining (~0.192 mg/L)2×t½ (34h): 25% remaining (~96.1 µg/L)3×t½ (51h): 12.5% remaining (~48 µg/L)4×t½ (68h): 6.3% remaining (~24 µg/L)5×t½ (3.5d): 3.1% remaining (~12 µg/L)
Plasma (PO)t½ Decay (17h)
  • 0×t½0h100% (0.384 mg/L)
  • 1×t½17h50% (0.192 mg/L)
  • 2×t½34h25% (96.1 µg/L)
  • 3×t½51h12.5% (48 µg/L)
  • 4×t½68h6.3% (24 µg/L)
  • 5×t½3.5d3.1% (12 µg/L)
Elimination t½17h (PO)
Rate Constant (ke)0.0408 h⁻¹
Time to Peak (Tmax)2.47h
Est. Peak (Cmax)0.384 mg/L
Clearance (CL)16.3 L/h
97% Washout (5×t½)3.5d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References